Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies - Normandie Université
Article Dans Une Revue British Journal of Pharmacology Année : 2014

Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies

Résumé

The neuropeptide 26RFa and its cognate receptor GPR103 are involved in the control of food intake and bone mineralization. Here, we have tested, experimentally, the predicted ligand-receptor interactions by site-directed mutagenesis of GPR103 and designed point-substituted 26RFa analogues.

Dates et versions

hal-01973604 , version 1 (08-01-2019)

Identifiants

Citer

Cindy Neveu, Fabienne Dulin, Benjamin Lefranc, Ludovic Galas, Colas Calbrix, et al.. Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies. British Journal of Pharmacology, 2014, 171 (19), pp.4425-4439. ⟨10.1111/bph.12808⟩. ⟨hal-01973604⟩
43 Consultations
0 Téléchargements

Altmetric

Partager

More